5:53 PM
 | 
Oct 29, 2013
 |  BC Extra  |  Politics & Policy

Gates partners with GSK, Sanofi for vaccine development

The Bill & Melinda Gates Foundation on Tuesday launched a new funding program for vaccine development and announced two separate deals with pharmas. The foundation and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) will invest a combined $1.8 million on R&D to improve the thermostability...

Read the full 191 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >